News

Azafaros Receives FDA's IND Clearance and Fast Track Designation for Lead Asset AZ-3102

IB1001-301 Recruitment Complete

IntraBio Ltd: Nov 301 NPC UK Recruitment Update

IntraBio Ltd. is pleased to share that the Phase III pivotal trial with N-acetyl-L-leucine (IB1001-301) clinical trial has enrolled over 70% of the target number of patients in the second month of recruitment...

Cyclo Therapeutics Announces Publication of Phase 1 Data for Trappsol® Cyclo™ for the Treatment of Niemann-Pick Disease Type C1 (NPC1)

NPUK Annual Family Conference & Interactive Workshop on Niemann-Pick Diseases 2022 [PROGRAMME]

NPUK Chair, Will Evans: "...on behalf of the NPUK Board of Trustees, I have pleasure in welcoming you to our flagship events - the Interactive Workshop on Niemann-Pick Diseases and our Family Conference. We are pleased to be back at Wyboston Lakes; and to be able to bring our community together with once again.  As in previous years, the programme is full of interesting and valuable talks, presentations, and workshops, which will cover many thought-provoking areas of research and advances in treatments..."